Leveraging Semiconducting Polymer Nanoparticles for Combination Cancer Immunotherapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Immunology

Background:

• Cancer immunotherapy shows promise for advanced cancer but faces challenges with immune-related adverse events.
• Semiconducting polymer nanoparticles (SPNs) are biocompatible nanomaterials with potential for tumor elimination and immune response induction.
• SPNs can act as nanocarriers for immunomodulators, enhancing anti-tumor immunity.

Purpose of the Study:

• To comprehensively review SPNs-based combination cancer immunotherapy.
• To categorize SPNs' therapeutic modalities and loaded immunomodulators.
• To guide the development of novel nanomaterials for enhanced anti-tumor immune effects and clinical translation.

Main Methods:

• Literature review of SPNs in cancer immunotherapy.
• Categorization based on SPNs' therapeutic modalities (photothermal, photodynamic, sonodynamic therapy).
• Analysis of SPNs as nanocarriers for various immunomodulators.

Main Results:

• SPNs can eliminate tumors via multiple therapeutic modalities.
• SPNs effectively induce tumor immunogenic cell death.
• SPNs synergize with immunomodulators to amplify anti-tumor immune responses.

Conclusions:

• SPNs represent a versatile platform for combination cancer immunotherapy.
• Understanding SPNs' mechanisms can inspire novel nanomaterial design.
• Further research may accelerate the clinical translation of SPNs-based therapies.